ACN Newswire
Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being 9 May 2025 and the 12-month volume-weighted average price- The Partial offer provides Cordlife shareholders an opportunity to exit at a premium- Medeze views this as a strategic opportunity to invest with long-term intent and explore collaborations with Cordlife including promotion of services together for market expansion…
Read More
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited
Margherita Grumbles
09:20
Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being 9 May 2025 and the 12-month volume-weighted average price- The Partial offer provides Cordlife shareholders an opportunity to exit at a premium- Medeze views this as a strategic opportunity to invest with long-term intent and explore
